Pharmacological Study on Absorption of WE 941 OD Tablets in Japanese Healthy Male Volunteers

Boehringer Ingelheim

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Drug: WE 941 OD tablets

Study type: Interventional

Funder types: Industry

Identifiers

NCT02218671

263.506

Details and patient eligibility

About

Evaluation whether Brotizolam is absorbed through the mucous membrane of oral cavity when WE 941 OD tablets are administered in Japanese healthy male volunteers.

Sex: Male

Ages: 20 to 35 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Healthy male volunteers
• age 20 - 35 years
• body weight 50 - 80 kg
• Body Mass Index (BMI) +/- 20%

Trial design

10 participants in 2 patient groups

WE 941 OD under deglutition

Experimental group

Treatment:

Drug: WE 941 OD tablets

WE 941 OD under non-deglutition

Experimental group

Treatment:

Drug: WE 941 OD tablets